Findings Showed that Common Lupus Treatments Did Not Increase Risk for Cancer

Newly published research funded in part by the National Institutes of Health found that immunosuppressive drugs that treat lupus do not necessarily increase cancer risk. Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC studied most of the drugs commonly used to treat SLE including cyclophosphamide, a drug reserved for severe lupus cases and other chronic inflammatory rheumatic diseases.

Published in Annals of the Rheumatic Diseases this month, results showed that the risk for lymphoma in lupus patients treated with cyclophosphamide was less than 0.1% per year. In addition, people with lupus did not have an increased risk for lymphoma.